Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings in Brief: Urohealth Systems

This article was originally published in The Gray Sheet

Executive Summary

Urohealth Systems: Firm's board approves the redemption of series A preferred stock issued by Davstar, Inc., Urohealth's wholly owned subsidiary, for a total consideration of $6.20 per share. The repurchase will eliminate dividend accumulation of the shares, which accrue at 7% per year, Urohealth says. The company's board also votes to approve a $20 mil. revolving line of credit proposal from Bankers Trust. Proceeds from the line of credit are tabbed for "working capital needs"...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts